http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014167419-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_29df9d321d338c170a236eb709c6083c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fbcdb105756f552ddf2e9ae2cfcf40a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1eb4b1ad8214e07b83141ea46d6336a |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 |
| filingDate | 2013-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_511f0cc8b33b0ad375de382df441a3e3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_099ef54fef260a441b640bddb70bb6a1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26aece98a89b1acd08d311e24824f320 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d047efdbddf8eeeab4eddb423f64ac42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_937d158ebd40d5ab3bd7ae07123eb059 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2514225eba4329d26703cf7cf3839ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c5843eb7bd070d81f6bab3fa5a5329b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_798639080330acfc417d713251f6edf8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_048e208823887eb15141aebb9c7f63ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d86d161af07ec48236696631db0769f |
| publicationDate | 2014-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2014167419-A |
| titleOfInvention | Combination of molecular markers and its expression analysis method for early detection of pleural mesothelioma patients |
| abstract | To develop a simple, inexpensive and reliable mesothelioma examination method and a kit used for the examination method. The present invention relates to a step of measuring the concentration of human periostin protein in at least one sample of blood and pleural effusion of a subject, and the human MPF protein in the blood sample of the subject. Measuring the concentration, and a method for examining mesothelioma. The step of measuring the concentration of the human periostin protein may use an antibody against the human periostin protein. The present invention provides a kit for diagnosing mesothelioma, comprising an antibody against human periostin protein and an antibody against human MPF protein. In the kit for diagnosing mesothelioma of the present invention, the diagnosis of mesothelioma may determine whether the subject who is likely to have mesothelioma is a mesothelioma patient or a healthy person . In the kit for diagnosing mesothelioma of the present invention, the mesothelioma is diagnosed by determining whether the subject who is likely to be mesothelioma is a mesothelioma patient or a respiratory disease other than mesothelioma. It may be determined whether the patient. [Selection] Figure 9 |
| priorityDate | 2013-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 177.